NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +168 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Clinical trial condition
Unresectable Gastric Adenocarcinoma
Explore clinical trials studying Unresectable Gastric Adenocarcinoma. Study availability and eligibility vary by location and protocol.
7 public trials
3 recruiting studies
Unresectable Gastric Adenocarcinoma trial results
NCT06203600
- Conditions
- Adenocarcinoma Of Esophagus, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, +14 more
- Locations
-
- Baptist Health Medical Center - Little Rock Little Rock, Arkansas, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim Anaheim, California, United States
- Kaiser Permanente-Baldwin Park Baldwin Park, California, United States
NCT05677490
- Conditions
- Adenocarcinoma Of Esophagus, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, +13 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Not yet recruiting
Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
NCT07594548
- Conditions
- Adenocarcinoma Of Esophagus, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, +14 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Ohio State University Columbus, Ohio, United States
Active, not recruiting
Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer
NCT03641313
- Conditions
- Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, +5 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
Active, not recruiting
Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma
NCT05041153
- Conditions
- Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Gastric Cancer AJCC v8, +30 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer
NCT06251973
- Conditions
- Adenocarcinoma Of Esophagus, Advanced Unresectable Gastric Adenocarcinoma, Digestive System Diseases, +22 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (Limited protocol activities) Commack, New York, United States
Related conditions
- Metastatic Gastric Adenocarcinoma (7)
- Metastatic Gastroesophageal Junction Adenocarcinoma (7)
- Clinical Stage III Gastric Cancer AJCC v8 (6)
- Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 (6)
- Clinical Stage IV Gastric Cancer AJCC v8 (6)
- Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 (6)
- Unresectable Gastroesophageal Junction Adenocarcinoma (6)
- Adenocarcinoma Of Esophagus (4)